Effects of etifoxine: Chemoreactome simulation
Objective: to simulate the biological properties of etifoxine. This simulation has been carried out for the first time. Material and methods. Reliable estimates of more than 2,500 biological activities were obtained for this molecule, which were compared with the reference drug lorazepam (benzodiazepine). Results and discussion. The data obtained from chemoreactome simulation may suggest that there are significant differences between the pharmacological effects of etifoxine and benzodiazepine in: 1) the selectivity of binding to various neurotransmitter receptors; 2) anti-inflammatory activity; 3) the effect on hemodynamics and vascular walls; 4) negative side effects and 5) pharmacokinetic parameters. Conclusion. The findings are consistent with the available experimental and clinical data and are indicative of promising clinical applications of etifoxine.